Dr. Reddy's Laboratories to acquire branded generics business in India

Dr. Reddy's Laboratories will acquire select divisions of Wockhardt Limited's branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives.

Dr. Reddy's will acquire 62 brands across an array of specialties including neurology, dermatology, gastroenterology and pain management. The company will acquire all assets, including the sales and marketing teams and a manufacturing plant. Dr. Reddy's expects the transaction to close in the first quarter of the 2020 fiscal year.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.